HER-2 negative breast cancer is an aggressive type of breast cancer that lacks human epidermal growth factor receptor 2 (HER2) protein over-expression or HER2 gene amplification. The conventional treatment of HER-2 negative breast cancer involves a combination of surgery, chemotherapy and radiation therapy depending on the stage and characteristics of cancer. New targeted therapies are being...
HER-2 negative breast cancer refers to breast cancer that does not have excess amounts of the human epidermal growth factor receptor 2 (HER2) protein. HER2-targeted therapies work well for HER2-positive cancers, but new treatment options are still needed for HER2-negative disease, which accounts for around 70% of all breast cancer cases. The HER-2 negative breast cancer treatment market has...